TY - JOUR T1 - What is behind programmatic treatment outcome definitions for tuberculosis? JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.01751-2020 VL - 56 IS - 1 SP - 2001751 AU - Zaza Avaliani AU - Ogtay Gozalov AU - Giorgi Kuchukhidze AU - Alena Skrahina AU - Viorel Soltan AU - Martin van den Boom AU - Irina Vasilyeva AU - Valentina Vilc AU - Askar Yedilbayev Y1 - 2020/07/01 UR - http://erj.ersjournals.com/content/56/1/2001751.abstract N2 - Following the launch of the DOTS (directly observed treatment, short-course) strategy in 1995, the World Health Organization (WHO) recommended the evaluation of treatment outcomes [1, 2]. The methodology and the forms for recording and reporting, in order to programmatically evaluate the proportion of tuberculosis (TB) cases achieving treatment success (“cured” and “treatment completed”; table 1) or dying, failing treatment and being lost to follow-up, were initially developed by Karel Styblo in the 1980s as part of the pilot programme of TB control in Tanzania [1, 2].Rationale for programmatic TB definitions in management of TB and MDR-TB https://bit.ly/36BYD2E ER -